Emphysema Treatment Market Report 2026

Emphysema Treatment Market Overview

• Emphysema Treatment market size has reached to $5.4 billion in 2025 • Expected to grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth • Market Trend: Product Innovations Reshaping The Emphysema Treatment Market • North America was the largest region in 2025.

What Is Covered Under Emphysema Treatment Market?

Emphysema treatment is a medication for chronic obstructive pulmonary disease (COPD) that causes damage to the lungs' air sacs, making breathing difficult. Emphysema treatments are available to control symptoms and decrease disease development of emphysema. The main treatments for emphysema treatment are smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, surgery transplants, and others. Smoking cessation is the process of stopping smoking to reduce the risk of cancer and other major health issues by minimizing cravings and withdrawal symptoms while inhibiting nicotine binding. These are distributed through various distribution channels such as online providers, drug stores and retail pharmacies, and hospital pharmacies. These are used by various end-users such as clinics, surgical centers, and others.

What Is The Emphysema Treatment Market Growth Forecast?

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $7.91 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to advancements in gene therapy, rising adoption of digital health solutions, growing home healthcare services, development of portable oxygen devices, increasing demand for minimally invasive surgeries. Major trends in the forecast period include personalized treatment plans, home-based care solutions, minimally invasive therapies, telehealth & remote monitoring, advanced pulmonary rehabilitation programs.

Global Emphysema Treatment Market Segmentation

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments 2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies 3) By End-User: Clinics, Surgical Centre, Other End-Users Subsegments: 1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs 2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics 3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers 4) By Leukotriene Modifiers: Montelukast, Zafirlukast 5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems 6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines 7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides 8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation 9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

What Is The Driver Of The Emphysema Treatment Market?

The rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases is expected to propel the growth of the emphysema treatment market going forward. Chronic obstructive pulmonary disease (COPD) is a set of disorders that cause airflow obstruction and breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are essential in reducing the advancement of Chronic Obstructive Pulmonary Disease (COPD) as they focus on treating symptoms, restoring lung function, and delaying disease progression. For instance, in December 2023, according to a research study published by JAMA Network Open, a medical journal by the American Medical Association, the global burden of chronic obstructive pulmonary disease (COPD) projected that the cases worldwide could reach nearly 600 million by 2050, marking a 23% increase in prevalence. Therefore, the rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases drives the emphysema treatment industry.

Key Players In The Global Emphysema Treatment Market

Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.

Global Emphysema Treatment Market Trends and Insights

Major companies operating in the emphysema market are developing innovative products such as inhalation aerosols to gain a competitive edge in the market. Inhalation aerosols refer to pharmaceutical formulations that are dispensed as a fine mist or spray of liquid medication suspended in a propellant or a mixture of propellants. For instance, in July 2023, Viatris Inc., a US-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a US-based pharmaceutical contract development and manufacturing organization (CDMO), launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, marking the first FDA-approved generic version of AstraZeneca's Symbicort for patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. This drug-device combination product, available in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths, signifies a crucial advancement in providing accessible and cost-effective treatment options for individuals facing respiratory challenges. Breyna is designed to address the maintenance treatment of airflow obstruction, reduce exacerbations in COPD patients, and manage asthma symptoms in patients six years and older, including those with emphysema.

What Are Latest Mergers And Acquisitions In The Emphysema Treatment Market?

In March 2023, UC Davis Health, a US-based academic health institution, collaborated with Propeller Health to deliver individualized treatment for chronic obstructive pulmonary disease and asthma using remote patient monitoring technology. With this collaboration, UC Davis Health would provide eligible patients with a Propeller Health remote patient monitoring (RPM) service that delivers individualized therapy for high-risk chronic obstructive pulmonary disease (COPD) and asthma using sensors, a smartphone application, and a website. Propeller Health is a US-based mobile platform company that provides sensors, mobile apps, analytics, and services to assist respiratory health management.

Regional Insights

North America was the largest region in the emphysema treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Emphysema Treatment Market?

The emphysema treatment market includes revenues earned by entities by providing medical services such as bronchodilator medications, anti-inflammatory medication, oxygen therapy, lifestyle change consultation, and interventional therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Emphysema Treatment Market Report 2026?

The emphysema treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the emphysema treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.